(Q36288929)
Statements
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation (English)
Christian Ott
Agnes Jumar
Kristina Striepe
Stefanie Friedrich
23 February 2017
1 reference